DrugPatentWatch Database Preview
Details for Patent: 9,840,505
» See Plans and Pricing
Which drugs does patent 9,840,505 protect, and when does it expire?
Patent 9,840,505 protects COPIKTRA and is included in one NDA.
This patent has thirty-seven patent family members in twenty-one countries.
Summary for Patent: 9,840,505
| Title: | Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereof |
| Abstract: | Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof. |
| Inventor(s): | Ren; Pingda (San Diego, CA), Martin; Michael (San Marcos, CA), Isbester; Paul (Castleton, NY), Lane; Benjamin S. (Lynnfield, MA), Kropp; Jason (Westford, MA) |
| Assignee: | Infinity Pharmaceuticals, Inc. (Cambridge, MA) |
| Application Number: | 15/016,117 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 9,840,505
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verastem Inc | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-001 | Sep 24, 2018 | RX | Yes | No | Start Trial | Start Trial | FOR THE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA (FL) | Start Trial | ||||
| Verastem Inc | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-001 | Sep 24, 2018 | RX | Yes | No | Start Trial | Start Trial | FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR SMALL LYMPHOCYTIC LEUKEMIA (SLL) | Start Trial | ||||
| Verastem Inc | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-002 | Sep 24, 2018 | RX | Yes | Yes | Start Trial | Start Trial | FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR SMALL LYMPHOCYTIC LEUKEMIA (SLL) | Start Trial | ||||
| Verastem Inc | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-002 | Sep 24, 2018 | RX | Yes | Yes | Start Trial | Start Trial | FOR THE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA (FL) | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,840,505
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 084824 | Start Trial | |||
| Australia | 2012205669 | Start Trial | |||
| Australia | 2015258280 | Start Trial | |||
| Canada | 2824197 | Start Trial | |||
| Chile | 2013002007 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
